NZ709362A - Process for the preparation of 1-([1,3]dioxolan-4-ylmethyl)-1h-pyrazol-3-ylamine - Google Patents
Process for the preparation of 1-([1,3]dioxolan-4-ylmethyl)-1h-pyrazol-3-ylamineInfo
- Publication number
- NZ709362A NZ709362A NZ709362A NZ70936213A NZ709362A NZ 709362 A NZ709362 A NZ 709362A NZ 709362 A NZ709362 A NZ 709362A NZ 70936213 A NZ70936213 A NZ 70936213A NZ 709362 A NZ709362 A NZ 709362A
- Authority
- NZ
- New Zealand
- Prior art keywords
- preparation
- ylamine
- dioxolan
- pyrazol
- ylmethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
- C07D231/40—Acylated on said nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012087380 | 2012-12-25 | ||
| PCT/EP2013/077563 WO2014102164A1 (en) | 2012-12-25 | 2013-12-20 | Process for the preparation of 1-([1,3]dioxolan-4-ylmethyl)-1h-pyrazol-3-ylamine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ709362A true NZ709362A (en) | 2019-07-26 |
Family
ID=49876646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ709362A NZ709362A (en) | 2012-12-25 | 2013-12-20 | Process for the preparation of 1-([1,3]dioxolan-4-ylmethyl)-1h-pyrazol-3-ylamine |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US9388168B2 (enExample) |
| EP (1) | EP2938609B1 (enExample) |
| JP (1) | JP6297590B2 (enExample) |
| KR (1) | KR102122569B1 (enExample) |
| CN (1) | CN105051031B (enExample) |
| AU (1) | AU2013369473B2 (enExample) |
| BR (1) | BR112015015229B1 (enExample) |
| CA (1) | CA2896155C (enExample) |
| CY (1) | CY1119040T1 (enExample) |
| DK (1) | DK2938609T3 (enExample) |
| ES (1) | ES2629313T3 (enExample) |
| HR (1) | HRP20170653T1 (enExample) |
| HU (1) | HUE032621T2 (enExample) |
| IL (1) | IL239558A (enExample) |
| LT (1) | LT2938609T (enExample) |
| NZ (1) | NZ709362A (enExample) |
| PL (1) | PL2938609T3 (enExample) |
| PT (1) | PT2938609T (enExample) |
| RU (1) | RU2621725C2 (enExample) |
| SG (1) | SG11201504951TA (enExample) |
| SI (1) | SI2938609T1 (enExample) |
| WO (1) | WO2014102164A1 (enExample) |
| ZA (1) | ZA201504601B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11266630B2 (en) * | 2016-12-15 | 2022-03-08 | Hua Medicine (Shanghai) Ltd. | Oral preparation of glucokinase activator and preparation method therefor |
| CN113493442B (zh) * | 2020-04-03 | 2024-11-08 | 天津药物研究院有限公司 | 作为葡萄糖激酶活化剂的吡咯烷酮衍生物及其制备方法和用途 |
| US11813274B2 (en) | 2020-04-22 | 2023-11-14 | Hua Medicine (Shanghai) Ltd. | Treating untreated or treatment-resistant diabetes with glucokinase activator and sodium-glucose cotransporter-2 inhibitor |
| WO2021212360A1 (en) * | 2020-04-22 | 2021-10-28 | Hua Medicine (Shanghai) Ltd. | Treating untreated or treatment-resistant diabetes with glucokinase activator and sodium-glucose cotransporter-2 inhibitor |
| CN111732543A (zh) * | 2020-08-14 | 2020-10-02 | 浙江鼎龙科技有限公司 | 一种4,5-二氨基-1-（2-羟乙基）吡唑硫酸盐的制备方法 |
| CN113750100B (zh) * | 2021-08-31 | 2022-12-30 | 海南中济医药科技有限公司 | 一种含有多扎格列艾汀与西格列汀的药物组合物及其制备方法 |
| AR127064A1 (es) * | 2021-09-15 | 2023-12-13 | Hua Medicine Shanghai Ltd | Prodroga de derivados de pirrolidona como activador de glucoquinasa |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4160841A (en) * | 1977-01-31 | 1979-07-10 | Janssen Pharmaceutica, N.V. | Heterocyclic derivatives of 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles |
| FR2748274B1 (fr) * | 1996-05-03 | 1998-06-12 | Oreal | Nouveaux diamino pyrazoles, leur synthese, compositions de teinture des fibres keratiniques les contenant, procede de teinture des fibres keratiniques |
| KR20100113518A (ko) * | 2008-01-18 | 2010-10-21 | 아스텔라스세이야쿠 가부시키가이샤 | 페닐아세트아미드 유도체 |
| US7741327B2 (en) * | 2008-04-16 | 2010-06-22 | Hoffmann-La Roche Inc. | Pyrrolidinone glucokinase activators |
| US8178689B2 (en) * | 2010-06-17 | 2012-05-15 | Hoffman-La Roche Inc. | Tricyclic compounds |
-
2013
- 2013-12-20 HU HUE13811542A patent/HUE032621T2/en unknown
- 2013-12-20 SI SI201330684A patent/SI2938609T1/sl unknown
- 2013-12-20 AU AU2013369473A patent/AU2013369473B2/en active Active
- 2013-12-20 NZ NZ709362A patent/NZ709362A/en unknown
- 2013-12-20 CN CN201380068179.8A patent/CN105051031B/zh active Active
- 2013-12-20 PT PT138115423T patent/PT2938609T/pt unknown
- 2013-12-20 ES ES13811542.3T patent/ES2629313T3/es active Active
- 2013-12-20 KR KR1020157019691A patent/KR102122569B1/ko active Active
- 2013-12-20 US US14/655,287 patent/US9388168B2/en active Active
- 2013-12-20 JP JP2015550041A patent/JP6297590B2/ja active Active
- 2013-12-20 DK DK13811542.3T patent/DK2938609T3/en active
- 2013-12-20 RU RU2015126911A patent/RU2621725C2/ru active
- 2013-12-20 PL PL13811542T patent/PL2938609T3/pl unknown
- 2013-12-20 LT LTEP13811542.3T patent/LT2938609T/lt unknown
- 2013-12-20 SG SG11201504951TA patent/SG11201504951TA/en unknown
- 2013-12-20 BR BR112015015229-5A patent/BR112015015229B1/pt active IP Right Grant
- 2013-12-20 HR HRP20170653TT patent/HRP20170653T1/hr unknown
- 2013-12-20 CA CA2896155A patent/CA2896155C/en active Active
- 2013-12-20 WO PCT/EP2013/077563 patent/WO2014102164A1/en not_active Ceased
- 2013-12-20 EP EP13811542.3A patent/EP2938609B1/en active Active
-
2015
- 2015-06-21 IL IL239558A patent/IL239558A/en active IP Right Grant
- 2015-06-25 ZA ZA2015/04601A patent/ZA201504601B/en unknown
-
2017
- 2017-07-10 CY CY20171100727T patent/CY1119040T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ709362A (en) | Process for the preparation of 1-([1,3]dioxolan-4-ylmethyl)-1h-pyrazol-3-ylamine | |
| MY160241A (en) | 5-alkynyl-pyrimidines | |
| PH12015500211B1 (en) | 4-methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalenes | |
| NZ592226A (en) | Use of dithiin tetracarboximides for treating phytopathogenic fungi for protecting plants | |
| IN2012DN02751A (enExample) | ||
| IN2014DN05772A (enExample) | ||
| MX359146B (es) | Compuesto como inhibidor de señalización wnt, composición y uso de los mismos. | |
| MX341456B (es) | Amino-quinolinas como inhibidores de cinasa. | |
| EA024194B8 (ru) | Содержащие диарилацетиленгидразид ингибиторы тирозинкиназы | |
| IN2015DN01061A (enExample) | ||
| TN2013000400A1 (en) | Imidazopyridazines as akt kinase inhibitors | |
| PH12013501859A1 (en) | Indolecarboxamides and benzimidazolecarboxamides as insecticides and acaricides | |
| MY160625A (en) | Process for preparing pan-cdk inhibitors of the formula(i), and intermediates in the preparation | |
| MX360806B (es) | Benzoxazinonas de carbamato. | |
| MX348979B (es) | Agente de control de enfermedades de las plantas. | |
| MY165487A (en) | Process for preparing a polyol ether | |
| MX2010009837A (es) | Tiazolil-dihidro-indazoles. | |
| MX359399B (es) | Inhibidores de 17alfa-hidroxilasa/c17-20-liasa. | |
| TN2011000531A1 (en) | 5- alkynyl - pyridines | |
| MX2012007837A (es) | Derivados de oxazolopirimidina 2, 5 - sustituidos. | |
| MX2015006828A (es) | Procedimiento de preparacion de derivados de acido 4-haloalquil-3-mercapto-2 sustituido-hidroxibenzoico. | |
| GB2523674A (en) | Compounds as inhibitor of DNA double-strand break repair, methods and applications thereof | |
| MX355654B (es) | Derivado de paroxetina. | |
| SA515360302B1 (ar) | مركبات رباعي أكسا ثنائي فوسفا سبيرو | |
| IN2013MU03015A (enExample) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 DEC 2020 BY CPA GLOBAL Effective date: 20191128 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 DEC 2021 BY CPA GLOBAL Effective date: 20201126 |
|
| ASS | Change of ownership |
Owner name: HUA MEDICINE (SHANGHAI) LTD., CN Effective date: 20210806 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 DEC 2022 BY CPA GLOBAL Effective date: 20211210 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 DEC 2023 BY CPA GLOBAL Effective date: 20221119 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 DEC 2024 BY CPA GLOBAL Effective date: 20231102 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 DEC 2025 BY ABHISHEK KUMAR - CPA-PTO PAYMENTS Effective date: 20241121 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 DEC 2026 BY ABHISHEK KUMAR - CPA-PTO PAYMENTS Effective date: 20251113 |